Introduction
Mechanism of ferroptosis
The canonical system XC-/GSH/GPX4 pathway
Lipid metabolism pathway
Iron metabolism pathway
Other metabolic pathways
Effect of ncRNA-mediated ferroptosis on tumor progression
miRNAs and ferroptosis
miRNA | Role in ferroptosis | Mechanism | Cancer | References |
---|---|---|---|---|
miR-670-3p | Inhibit | Downregulates ACSL4 | GBM | [107] |
miR-23a-3p | Inhibit | Downregulates ACSL4 | HCC | [108] |
miR-424-5p | Inhibit | Downregulates ACSL4 | OC | [40] |
miR-7-5p | Inhibit | Downregulates mitoferrin | OC, OSCC and HCC | [41] |
miR-7-5p | Inhibit | Upregulates ferritin, downregulates ALOX12 | Cervical cancer, OSCC | [41] |
exo-miR-522 | Inhibit | Downregulates ALOX15 | GC | [44] |
miR-18a | Inhibit | Downregulates ALOXE3 | GBM | [109] |
miR-214-3p | Promote | Downregulates ATF4 | HCC | [110] |
miR-3200-5p | Promote | Downregulates ATF4 | HCC | [111] |
miR-155 | Promote | Downregulates Foxo3a | Pancreatic cancer | [112] |
miR-4735-3p | Promote | Downregulates FPN | CCRCC | [113] |
exo-miR-4443 | Inhibit | Downregulates m6A, Upregulates FSP1 | NSCLC | [45] |
miR-1228 | Inhibit | Upregulates FSP1 | Breast cancer | [114] |
miR-4715-3p | Promote | Downregulates AURKA and GPX4 | UGC | [115] |
miR-9 | Inhibit | Downregulates GOT1 | Melanoma | [116] |
miR-15a-3p | Promote | Downregulates GPX4 | CRC | [117] |
miR-539 | Promote | Downregulates GPX4 | CRC | [118] |
miR-324-3p | Promote | Downregulates GPX4 | Breast cancer | [37] |
miR-324-3p | Promote | Downregulates GPX4 | NSCLC | [119] |
miR-15a | Promote | Downregulates GPX4 | PCa | [120] |
miR-1287-5p | Promote | Downregulates GPX4 | Osteosarcoma | [121] |
miR-29b | Promote | Downregulates GPX7 | glioma | [122] |
miR-19a | Inhibit | Downregulates IREB2 | CRC | [123] |
miR-130b-3p | Inhibit | Downregulates DKK1, upregulates NRF2 and HO-1 | Melanoma | [124] |
miR-7 | Inhibit | Downregulates Keap1, upregulates NRF2 | Human neuroblastoma | [125] |
miR-200a | Inhibit | Upregulates NRF2 | Breast cancer | [38] |
miR-200a | Inhibit | Upregulates Keap1 and NRF2 | ESCC | [39] |
miR-6077 | Promote | Downregulates NRF2 | LUAD | [126] |
miR-450b-5p | Promote | Downregulates NRF2 | NPC | [127] |
miR-365a-3p | Promote | Downregulates NRF2 | NSCLC | [128] |
miR-137 | Inhibit | Downregulates SLC1A5 | Melanoma | [129] |
miR-382-5p | Promote | Downregulates SLC7A11 | Ovarian, breast cancer | [130] |
miR-489-5p | Promote | Downregulates SLC7A11 | GC | [131] |
miR-125b-5p | Promote | Downregulates SLC7A11 | OSCC | [132] |
miR-34c-3p | Promote | Downregulates SLC7A11 | OSCC | [133] |
miR-1261 | Promote | Downregulates SLC7A11 | HCC | [134] |
miR-25-3p | Promote | Downregulates SLC7A11 | PCa | [134] |
miR-27a | Promote | Downregulates SLC7A11 | Bladder cancer | [135] |
miR-375 | Promote | Downregulates SLC7A11 | GC | [136] |
miR-5096 | Promote | Downregulates SLC7A11 | Breast cancer | [137] |
miR-489-3p | Promote | Downregulates SLC7A11 | GC | [131] |
miR-139-5p | Promote | Downregulates SLC7A12 | Pancreatic carcinoma | [138] |
miR-27a-3p | Inhibit | Downregulates SLC7A11 | NSCLC | [139] |
miR-125b-5p | Promote | Downregulates STAT3 | GC | [140] |
miR-101-3p | Promote | Downregulates TBLR1 | LC | [141] |
miR-545 | Inhibit | Downregulates TF | CRC | [142] |
miR-21-3p | Promote | Downregulates TXNRD1 | Melanoma | [143] |
lncRNA and ferroptosis
IncRNA | Role in ferroptosis | Mechanism | Cancer | References |
---|---|---|---|---|
NEAT1 | Inhibit | Upregulates ACSL4 | NSCLC | [144] |
lncRNA ASMTL-AS1 | Promote | Upregulates SAT1 | LUAD | [145] |
NEAT1 | Promote | Sponges miR-362-3p to upregulate MIOX | HCC | [146] |
NEAT1 | Inhibit | Downregulate SLC7A11 | Melanoma | [103] |
LINC00551 | Promote | Sponges miR-4328 to upregulate DDIT4 | LUAD | [102] |
H19 | Inhibit | Inhibits production of lipid ROS and induces production of GSH | Breast cancer | [147] |
H19 | Inhibit | Sponges miR 19b-3p to upregulate FTH1 | LC | [148] |
TUG1 | Promote | Downregulates FTH1 | Glioma | [149] |
Lnc GABPB1-AS1 | Promote | Downregulates GABPB1 and PRDX5 | HCC | [150] |
lncRNA BBOX1-AS1 | Inhibit | Sponges miR-513a-3p to downregulate SLC7A11 | Esophageal squamous cell cancer | [151] |
LINC00618 | Promote | Interacts with LSH to downregulate SLC7A11 | Leukemia | [152] |
P53RRA (LINC00472) | Promote | Interacts with G3BP1 to downregulate SLC7A11 | LC | [99] |
OIP5-AS1 | Inhibit | Sponges miR-128-3p to upregulate SLC7A11 | Prostate cancer | [153] |
lncRNA slc16a1-AS1 | Inhibit | Sponges miR-143-3p to upregulate SLC7A11 | Renal cell carcinoma | [154] |
HEPVAL | Promote | Downregulate SLC7A11 | HCC | [155] |
lncFERO | Inhibit | Interacts with hnRNPA1 to upregulate SCD1 | GC | [47] |
lncBDNF-AS | Inhibit | Interacts with WDR5 and FBXW7 to upregulate VDAC3 | GC | [156] |
RP11-89 | Inhibit | Sponges miR-129-5p to upregulate PROM2 | Bladder cancer | [157] |
lncLASTR | Inhibit | Upregulates GPX4 | Stomach adenocarcinoma | [158] |
lncPVT1 | Inhibit | Sponges miR-214-3p to upregulate GPX4 | HCC | [52] |
HCG18 | Inhibit | Sponges miR-450b-5p to upregulate GPX4 | HCC | [159] |
MEG8 | Inhibit | Sponges miR-497-5p to upregulate NOTCH2 | Benign hemangioma | [160] |
lncRNA TMEM161B-AS1 | Inhibit | Sponges mir-27a-3p to upregulate FANCD2 and CD44 | Glioma | [161] |
lncRNA MT1DP | Promote | Sponges miR-365a-3p to downregulate NRF2 | NSCLC | [128] |
LINC01606 | Inhibit | Sponges miR-423-5p to upregulate SCD1 | Colon cancer | [162] |
LINC00336 | Inhibit | Sponges miR6852 to upregulate CBS | LC | [163] |
LINC01564 | Inhibit | Upregulate NFE2L2 | Glioma | [164] |
circRNA and ferroptosis
circRNA | Role in ferroptosis | Mechanism | Cancer | References |
---|---|---|---|---|
Hsa_circ_0021087 (circLMO1) | Promote | Sponges miR-4291 to upregulate ACSL4 | Cervical cancer | [165] |
circGFRA1 | Inhibit | Sponges miR‐1228 to upregulate AIFM2 | Breast cancer | [114] |
Circ clARS | Promote | Interacts with ALKBH5 | HCC | [101] |
CircABCB10 | Inhibit | Sponges miR-326 to upregulate CCL5 | Rectal cancer | [166] |
Circ_0008035 | Inhibit | Sponges miR-599 to upregulate EIF4A1 | GC | [167] |
circPVT1 | Inhibit | Sponges miR-30a-5p to upregulate FZD3 | Esophageal cancer | [168] |
circ_0007142 | Inhibit | Sponges miR-874-3p, upregulates GDPD5 | CRC | [169] |
circKIF4A | Inhibit | Sponges miR-1231 to upregulate GPX4 | TPC | [66] |
circDTL | Inhibit | Sponges miR-1287-5p to upregulate GPX4 | NSCLC | [100] |
CircIL4R | Inhibit | Sponges miR-541-3p to upregulate GPX4 | HCC | [119] |
Circ-TTBK2 | Inhibit | Sponges miR-761 to upregulate ITGB8 | Glioma | [170] |
Circ_0000745 | Inhibit | Sponges miR-494-3p to upregulate NET1 | ALL | [62] |
circCDK14 | Inhibit | Sponges miR-3938 to upregulate PDGFRA | Glioma | [171] |
circKDM4C | Promote | Sponges miRNA let-7b-5p to upregulate p53 | AML | [172] |
circ0097009 | Inhibit | Sponges miR-1261 to upregulate SLC7A11 | HCC | [134] |
circEPSTI1 | Inhibit | Sponges miR-375, miR-409-3p and miR-515-5p to upregulate SLC7A11 | Cervical cancer | [173] |
circFNDC3B | Inhibit | Sponges miR-520d-5p to upregulate SLC7A11 | OSCC | [174] |
circ_0067934 | Inhibit | Sponges miR-545-3p to upregulate SLC7A11 | Papillary and follicular thyroid cancers | [175] |
circ-BGN | Inhibit | Upregulates OTUB1 and SLC7A11 | Breast cancer | [59] |
circFOXP3 | Inhibit | Sponges miR-7a-11p to upregulate SLC520A5 | LC | [176] |
circRHOT1 | Inhibit | Sponges miR-106a-5p to upregulate STAT3 | Breast cancer | [177] |
circ_0000190 | Promote | Sponges miR-382-5p to upregulate ZNRF3 | GC | [178] |
Relationship between ferroptosis and other PCDs
Apoptosis and ferroptosis
Necroptosis and ferroptosis
Autophagy and ferroptosis
Pyroptosis and ferroptosis
Cuproptosis and ferroptosis
Role of ncRNA in crosstalk between ferroptosis and other PCDs in tumors
ncRNA | Role in PCDs | Mechanism | Cancer | References |
---|---|---|---|---|
lncRNA NEAT1 | Promote ferroptosis and apoptosis | Sponges miR-362-3p to upregulate MIOX | HCC | [146] |
lncRNA P53RRA (LINC00472) | Promote ferroptosis and apoptosis | Interacts with G3BP1 to downregulate SLC7A11 | LC | [99] |
lncRNA OIP5-AS1 | Inhibit ferroptosis and apoptosis | Sponges miR-128-3p to upregulate SLC7A11 | PCa | [153] |
lncRNA HCG18 | Inhibit ferroptosis and apoptosis | Sponges miR-450b-5p to upregulate GPX4 | HCC | [159] |
lncRNA TMEM161B-AS1 | Inhibit ferroptosis and apoptosis | Sponges mir-27a-3p to upregulate FANCD2 and CD44 | Glioma | [161] |
LINC01564 | Inhibit ferroptosis and apoptosis | Upregulate NFE2L2 | Glioma | [164] |
CircABCB10 | Inhibit ferroptosis and apoptosis | Sponges miR-326 to upregulate CCL5 | Rectal cancer | [166] |
circDTL | Inhibit ferroptosis and apoptosis | Sponges miR-1287-5p to upregulate GPX4 | NSCLC | [100] |
Circ_0000745 | Inhibit ferroptosis and apoptosis | Sponges miR-494-3p to upregulate NET1 | ALL | [62] |
circRHOT1 | Inhibit ferroptosis and apoptosis | Sponges miR-106a-5p to upregulate STAT3 | Breast cancer | [177] |
circ_0007142 | Inhibit ferroptosis and apoptosis | Sponges miR-874-3p, upregulates GDPD5 | CRC | [169] |
Hsa_circ_0021087 (circLMO1) | Promote ferroptosis and apoptosis | Sponges miR-4291 to upregulate ACSL4 | Cervical Cancer | [165] |
LINC00618 | Promote ferroptosis in a manner dependent upon apoptosis | Interacts with LSH to downregulate SLC7A11 | leukemia | [152] |
NEAT1 | Inhibit ferroptosis and autophagy | upregulate SLC7A11 | melanoma | [103] |
LINC00551 | Promote ferroptosis in a manner dependent upon autophagy | Sponges miR-4328 to upregulate DDIT4 | LUAD | [102] |
lncRNA H19 | Inhibit autophagy-mediated ferroptosis | Inhibits production of lipid ROS and induces production of GSH | Breast cancer | [147] |
Circ clARS | Promote autophagy-mediated ferroptosis | Interacts with ALKBH5 | HCC | [101] |